Literature DB >> 23722339

What matters most in commercial success: first-in-class or best-in-class?

Ulrik Schulze1, Michael Ringel.   

Abstract

Mesh：

Year:  2013        PMID： 23722339     DOI： 10.1038/nrd4035

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

1.  Drug launch curves in the modern era.

Authors:  Seth Robey; Frank S David
Journal:  Nat Rev Drug Discov       Date:  2016-12-02       Impact factor: 84.694

2.  Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyond.

Authors:  Nigel H Greig; Debomoy K Lahiri
Journal:  Curr Alzheimer Res       Date:  2014-02       Impact factor: 3.498

3.  Nationwide Trends in Dispensing of Sodium Glucose Cotransporter 2 Inhibitors.

Authors:  Michael Fralick; Diana Martins; Mina Tadrous; Tara Gomes
Journal:  Can J Hosp Pharm       Date:  2022-04-04

4.  How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012.

Authors:  Derek J Ward; Angharad Slade; Tracey Genus; Orsolina I Martino; Andrew J Stevens
Journal:  BMJ Open       Date:  2014-10-24       Impact factor: 2.692

5.  Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions.

Authors:  Diana H Marcantonio; Andrew Matteson; Marc Presler; John M Burke; David R Hagen; Fei Hua; Joshua F Apgar
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

6.  Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents.

Authors:  Arisa Djurian; Tomohiro Makino; Yeongjoo Lim; Shintaro Sengoku; Kota Kodama
Journal:  J Pers Med       Date:  2021-05-24

Review 7.  Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.

Authors:  Shuvam Chaudhuri; Julian A Symons; Jerome Deval
Journal:  Antiviral Res       Date:  2018-05-15       Impact factor: 5.970
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.